Portage Biotech Inc., 10% Owner at Biohaven Pharmaceutical Holding Co Ltd. (BHVN), sold 4,350 shares at $28.62 ($124K) on 2018-01-04, disclosed to the SEC on 2018-01-11.
Open-market sale of $124k BHVN by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| Filing → |
| BHVN | SELL | 2018-01-04 | $2.0M | — | Filing → |